As east area director for the vast CEE market, Pawel Mazur explains how Accord Healthcare has gone from strength to strength in Poland, with the intention of becoming a top five generics company in the country by 2021. He also touches on the importance of a high-performing team, the exciting new changes within European operations and opportunities in the OTC market.
What is the scope of Accord Healthcare Poland’s operations?
"We will be the fifth generic company in Poland in the next three years, and as such, all of our activities are geared towards the achievement of this goal."
